SELLAS Life Sciences (SLS) Total Debt (2013 - 2018)

SELLAS Life Sciences (SLS) has 6 years of Total Debt data on file, last reported at $76000.0 in Q3 2018.

• Total Debt for Q3 2018 came in at $76000.0, down 99.38% year-over-year; the trailing twelve-month figure through Sep 2018 was $76000.0 (down 99.38% YoY), and the FY2017 annual result was $11.0 million, up 542.95% from the prior year.
• Total Debt retreated to $76000.0 in Q3 2018 per SLS's latest filing, from $7.8 million in the prior quarter.
• Over five years, Total Debt peaked at $23.7 million in Q3 2016 and troughed at $76000.0 in Q3 2018.
• A 5-year average of $9.5 million and a median of $9.3 million in 2014 frame the typical range for Total Debt.
• The sharpest annual moves came in 2017 and 2018: Total Debt jumped 542.95% in 2017, then tumbled 99.38% in 2018.
• A 5-year view of Total Debt shows it stood at $8.4 million in 2014, then plunged by 43.6% to $4.7 million in 2015, then tumbled by 63.94% to $1.7 million in 2016, then jumped by 542.95% to $11.0 million in 2017, then plunged by 99.31% to $76000.0 in 2018.
• Business Quant data shows SLS's Total Debt at $76000.0 in Q3 2018, $7.8 million in Q2 2018, and $9.7 million in Q1 2018.